Pancreatic Cancer Disparities and Hope

Pancreatic cancer is devastating Black communities at an alarming rate, with diagnoses often coming too late for surgery — and stars like Aretha Franklin and John Lewis among those lost. But breakthroughs are emerging: a new drug, daraxonrasib, could double survival rates when paired with chemo — a potential game-changer. Yet, this progress depends on sustained federal funding, which is now under threat from proposed cuts that could deepen health disparities. With policies also rolling back diversity and inclusion efforts, advocates are rallying to reinvest in research, expand healthcare access, and ensure no community is left behind in the fight for life-saving treatments. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e19256d7264d1074